CoChat
Sign Up
Cited by 20

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Regulation of intestinal LDLR by the LXR-IDOL axis

van Loon, Nienke M., van Wouw, Suzanne A.E., Ottenhoff, Roelof, Nelson, Jessica K., Kingma, Jenina, Scheij, Saskia, Moeton, Martina, Zelcer, Noam·2020·Atherosclerosis
DOI 10.1016/j.atherosclerosis.2020.10.898
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2020.10.898

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 40

  1. Calandra, 2011, Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk, J. Lipid Res., 52, 1885, 10.1194/jlr.R017855 · DOI
  2. Hotta, 1955, The role of the liver in the turnover of plasma cholesterol, Arch. Biochem. Biophys., 56, 28, 10.1016/0003-9861(55)90330-1 · DOI
  3. Dietschy, 1971, Cholesterol synthesis in the intestine of man: regional differences and control mechanisms, J. Clin. Invest., 50, 872, 10.1172/JCI106559 · DOI
  4. van der Wulp, 2013, Regulation of cholesterol homeostasis, Mol. Cell. Endocrinol., 368, 1, 10.1016/j.mce.2012.06.007 · DOI
  5. Ouimet, 2019, HDL and reverse cholesterol transport: basic mechanisms and their roles in vascular health and disease, Circ. Res., 124, 1505, 10.1161/CIRCRESAHA.119.312617 · DOI
  6. Temel, 2015, A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion, Trends Pharmacol. Sci., 36, 440, 10.1016/j.tips.2015.04.002 · DOI
  7. Jakulj, 2010, Ezetimibe stimulates faecal neutral sterol excretion depending on abcg8 function in mice, FEBS Lett., 584, 3625, 10.1016/j.febslet.2010.07.035 · DOI
  8. Jakulj, 2016, Transintestinal cholesterol transport is active in mice and humans and controls ezetimibe-induced fecal neutral sterol excretion, Cell Metabol., 24, 783, 10.1016/j.cmet.2016.10.001 · DOI
  9. Lifsey, 2020, Stigmasterol stimulates transintestinal cholesterol excretion independent of liver X receptor activation in the small intestine, J. Nutr. Biochem., 76, 10.1016/j.jnutbio.2019.108263 · DOI
  10. Nakano, 2018, Luminal plant sterol promotes brush border membrane-to-lumen cholesterol efflux in the small intestine, J. Clin. Biochem. Nutr., 63, 102, 10.3164/jcbn.17-116 · DOI
  11. de Boer, 2017, Intestinal farnesoid X receptor controls transintestinal cholesterol excretion in mice, Gastroenterology, 152, 1126, 10.1053/j.gastro.2016.12.037 · DOI
  12. Kruit, 2005, Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice, Gastroenterology, 128, 147, 10.1053/j.gastro.2004.10.006 · DOI
  13. Vrins, 2012, Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein, J. Lipid Res., 53, 2017, 10.1194/jlr.M022194 · DOI
  14. Brown, 2008, Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss, J. Biol. Chem., 283, 10522, 10.1074/jbc.M707659200 · DOI
  15. Marshall, 2014, Acute sterol O-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion, PloS One, 9, 10.1371/journal.pone.0098953 · DOI
  16. de Boer, 2018, Cholesterol transport revisited: a new turbo mechanism to drive cholesterol excretion, Trends Endocrinol. Metabol., 29, 123, 10.1016/j.tem.2017.11.006 · DOI
  17. Moreau, 2019, In vivo evidence for transintestinal cholesterol efflux in patients with complete common bile duct obstruction, J Clin Lipidol, 13, 10.1016/j.jacl.2018.09.010 · DOI
  18. Simmonds, 1967, Absorption of cholesterol from a micellar solution: intestinal perfusion studies in man, J. Clin. Invest., 46, 874, 10.1172/JCI105587 · DOI
  19. Cheng, 1959, Secretion of cholesterol by intestinal mucosa in patients with complete common bile duct obstruction, Exp. Biol. Med., 101, 223, 10.3181/00379727-101-24890 · DOI
  20. Paalvast, 2017, Developments in intestinal cholesterol transport and triglyceride absorption, Curr. Opin. Lipidol., 28, 248, 10.1097/MOL.0000000000000415 · DOI
  21. Engelking, 2012, Blockade of cholesterol absorption by ezetimibe reveals a complex homeostatic network in enterocytes, J. Lipid Res., 53, 1359, 10.1194/jlr.M027599 · DOI
  22. Howe, 2016, Cholesterol homeostasis: how do cells sense sterol excess?, Chem. Phys. Lipids, 199, 170, 10.1016/j.chemphyslip.2016.02.011 · DOI
  23. Hong, 2014, Liver X receptors in lipid metabolism: opportunities for drug discovery, Nat. Rev. Drug Discov., 13, 433, 10.1038/nrd4280 · DOI · Paper page
  24. Zelcer, 2006, Liver X receptors as integrators of metabolic and inflammatory signaling, J. Clin. Invest., 116, 607, 10.1172/JCI27883 · DOI · Paper page
  25. Zelcer, 2009, LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor, Science, 325, 100, 10.1126/science.1168974 · DOI · Paper page
  26. Van Loon, 2018, Inactivation of the E3 ubiquitin ligase idol attenuates diet-induced obesity and metabolic dysfunction in mice, Arterioscler. Thromb. Vasc. Biol., 38, 1785, 10.1161/ATVBAHA.118.311168 · DOI · Paper page
  27. Hong, 2010, The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2, J. Biol. Chem., 285, 19720, 10.1074/jbc.M110.123729 · DOI · Paper page
  28. Zeng, 2012, Liver X receptors agonists impede hepatitis C virus infection in an Idol-dependent manner, Antivir. Res., 95, 245, 10.1016/j.antiviral.2012.06.004 · DOI
  29. van Loon, 2019, The E3 ubiquitin ligase inducible degrader of the LDL receptor/myosin light chain interacting protein in health and disease, Curr. Opin. Lipidol., 30, 192, 10.1097/MOL.0000000000000593 · DOI
  30. Teslovich, 2010, Biological, clinical and population relevance of 95 loci for blood lipids, Nature, 466, 707, 10.1038/nature09270 · DOI · Paper page
  31. Sorrentino, 2013, Identification of a loss-of-function inducible degrader of the low-density lipoprotein receptor variant in individuals with low circulating low-density lipoprotein, Eur. Heart J., 34, 1292, 10.1093/eurheartj/ehs472 · DOI
  32. Tan, 2019, Differential use of E2 ubiquitin conjugating enzymes for regulated degradation of the rate-limiting enzymes HMGCR and SQLE in cholesterol biosynthesis, Atherosclerosis, 281, 137, 10.1016/j.atherosclerosis.2018.12.008 · DOI · Paper page
  33. Loregger, 2017, Assaying low-density-lipoprotein (LDL) uptake into cells, Methods Mol. Biol., 1583, 53, 10.1007/978-1-4939-6875-6_5 · DOI
  34. Hong, 2014, Short article the LXR – idol Axis differentially regulates plasma LDL levels in primates and mice, Cell Metabol., 20, 910, 10.1016/j.cmet.2014.10.001 · DOI · Paper page
  35. Reeskamp, 2018, Transintestinal cholesterol excretion in humans, Curr. Opin. Lipidol., 29, 10, 10.1097/MOL.0000000000000473 · DOI
  36. Hong, 2014, The LXR–Idol axis differentially regulates plasma LDL levels in primates and mice, Cell Metabol., 20, 910, 10.1016/j.cmet.2014.10.001 · DOI · Paper page
  37. Moschetta, 2015, Nuclear receptors and cholesterol metabolism in the intestine, Atherosclerosis Suppl., 17, 9, 10.1016/S1567-5688(15)50003-2 · DOI
  38. Bonamassa, 2013, Atherosclerosis: lessons from LXR and the intestine, Trends Endocrinol. Metabol., 24, 120, 10.1016/j.tem.2012.10.004 · DOI
  39. Le May, 2013, Transintestinal cholesterol excretion is an active metabolic process modulated by PCSK9 and statin involving ABCB1, Arterioscler. Thromb. Vasc. Biol., 33, 1484, 10.1161/ATVBAHA.112.300263 · DOI
  40. Meoli, 2019, Intestine-specific overexpression of LDLR enhances cholesterol excretion and induces metabolic changes in male mice, Endocrinology, 160, 744, 10.1210/en.2018-00098 · DOI

Cited by

Sorted by citations

Metadata

Authors
van Loon, N. M., van Wouw, S. A. E., Ottenhoff, R., Nelson, J. K., Kingma, J., Scheij, S., Moeton, M., & Zelcer, N.
ORCID
Venue
Atherosclerosis
Publisher
Elsevier BV
Published
2020-12
Volume
315
Pages
1-9
ISSN
0021-9150
DOI
10.1016/j.atherosclerosis.2020.10.898
Cited by
20
References
7
Language
en
Licence
Funders
  • European Research Council
  • Hartstichting
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review